| Head and Neck Carcinoma, Other studied in …STUDIED_INderived128 of 128show fewer |
|---|
| → studied in | NCT04216732recruiting Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07142005recruiting Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02293954NA · active not recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01660984active not recruiting Natural History Study of Children and Adults With Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04522570NA · completed Thermal Ablation of Cervical Metastases From Thyroid Carcinoma · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06176989Phase 2 · recruiting Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Sinonasal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04467021NA · active not recruiting Cancer and Blood Pressure Management, CARISMA Study · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07812779not yet recruiting Thyroid Health Outcomes Registry for Surgery · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06940180Phase 2 · recruiting Toripalimab With Chemotherapy for Sinus Cancer · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Sinonasal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867592Phase 2 · active not recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Sinonasal Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07050186Phase 2 · recruiting Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04280081Phase 2 · active not recruiting A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07713901enrolling by invitation Database Linkage Study to Evaluate the Risk of Medullary Thyroid Carcinoma · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05019716Phase 1/Phase 2 · recruiting Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05372640Phase 1 · recruiting Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07259304active not recruiting Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04877613Phase 1 · active not recruiting GFRα4 CAR T Cells in MTC Patients · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00707473Phase 2 · terminated Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Sinonasal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03892993NA · recruiting Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02856347NA · completed Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07661420Phase 1 · not yet recruiting 211At-MABG in Adults With Advanced Neuroendocrine Cancers · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Malignant Odontogenic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621146not yet recruiting A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04514484Phase 1 · active not recruiting Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07612293NA · not yet recruiting STAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04759911Phase 2 · active not recruiting Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02088645Phase 1 · active not recruiting 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01298323Phase 3 · completed Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03157128Phase 1/Phase 2 · active not recruiting A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05925491Phase 2 · recruiting Pembrolizumab in Locally Advanced Sinonasal Carcinoma · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Sinonasal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141369NA · recruiting Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07501650Phase 1 · recruiting Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Head and Neck Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04211337Phase 3 · active not recruiting A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07459127active not recruiting Multicenter Retrospective Cohort of Pulmonary NUT Carcinoma · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07383246Phase 3 · recruiting CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899792Phase 1/Phase 2 · active not recruiting A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07252661Phase 1 · not yet recruiting Study of ACC-1898 in Adult Participants With Advanced Solid Tumors · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05812027active not recruiting A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05265429recruiting Biology of Young Lung Cancer Study: The YOUNG LUNG Study · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01896479Phase 4 · active not recruiting A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07138716NA · recruiting Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072143recruiting An International Study on Pediatric Patients With Rare Tumors. · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07048964not yet recruiting A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05534594NA · completed Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03037385Phase 1/Phase 2 · completed Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03274414Phase 2 · completed A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Nasal Cavity Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00381641Phase 2 · completed Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06852144enrolling by invitation PET-TC in Thyroid Evaluation · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03906331approved for marketing Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05488548Phase 1 · recruiting Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06292988completed Predictive Factors for Medullary Thyroid Cancer Aggressiveness · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01945762completed Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04970134active not recruiting Spanish Study for Molecular Characterization of Thyroid Carcinoma · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00655655Phase 1 · completed Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06523582recruiting Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06520319Phase 1 · unknown Head-to-head Study of 68Ga-MGS5 Versus 68Ga-DOTATATE PET/CT in Patients With Medullary Thyroid Carcinoma · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01856920Phase 2 · completed QUILT-3.006 for Recurrent Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04161391Phase 1/Phase 2 · terminated Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02516553Phase 1 · completed BI 894999 First in Human Dose Finding Study in Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02592356NA · completed Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06277180NA · recruiting 68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390325Phase 2 · completed Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Hereditary Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06243965completed Is Desmoplastic Stromal Reaction Useful to Modulate Lymph Node Dissection in Sporadic Medullary Thyroid Carcinoma? · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05675605Phase 1/Phase 2 · unknown A Study of TY-1091 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04760288Phase 3 · withdrawn A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC). · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01709435Phase 1 · completed Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06121271Phase 2 · not yet recruiting Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06079723not yet recruiting A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06067594completed Calcitonin in Needle Wash Using Electrochemiluminescence Method For Diagnosis Of Medullary Thyroid Carcinoma. · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01586767NA · unknown Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Sinonasal Undifferentiated Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05830500Phase 4 · recruiting Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01511393enrolling by invitation An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC) · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05278364Phase 1/Phase 2 · unknown Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05796960unknown European Multicenter Study on Surgical Management of Advanced Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02431715no longer available 18F-FDOPA PET in Neuroendocrine Tumours · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02363647NA · terminated Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01730638Phase 1/Phase 2 · completed ImmunoTEP for Patients With Medullary Thyroid Carcinoma. · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04787328Phase 2 · unknown A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC) · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03647657early Phase 1 · completed 177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03838692Phase 2 · withdrawn Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04204928approved for marketing Pre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTC · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03630120Phase 2 · terminated Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04760171unknown Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal Amyloidosis · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03072160Phase 2 · completed Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02698176Phase 1 · terminated A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006) · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02259114Phase 1 · completed A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003) · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04721184unknown Impact of Low Muscle Mass in HNC Treated With Immunotherapy · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Head and Neck Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00514046Phase 1/Phase 2 · completed Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03643055unknown 18F-Fluorocholine PET/CT in Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02709889Phase 1/Phase 2 · terminated Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04116359Phase 1/Phase 2 · withdrawn Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106843Phase 2 · withdrawn Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01788982Phase 2 · completed Nintedanib(BIBF1120) in Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02174679no longer available 68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access) · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03246659Phase 1 · completed Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00625846Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00880503completed Collection of Tissue Samples for Study of Multidrug Resistance · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00582712Phase 2 · terminated An Initial Study of Lithium in Patients With Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00654238Phase 2 · completed Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02307240Phase 1 · completed Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | NUT Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02586350Phase 2/Phase 3 · completed Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031) · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00923247Phase 1/Phase 2 · terminated A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC) · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03636945NA · unknown Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid Carcinoma · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465424completed Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01424878completed Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831179Phase 1 · withdrawn Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01927887NA · completed Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01539655Phase 1 · completed Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02109250completed CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice · condition mapped CURATED_BROADER · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00519896Phase 2 · completed Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118248Phase 2 · completed Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01915485Phase 4 · unknown Radiolabeled Molecules for Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01757470completed Vandetanib Risk Minimisation Effectiveness · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01204476Phase 1 · completed Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01155258Phase 1 · completed Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01625520Phase 2 · completed SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00134043Phase 2 · completed Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01736878Phase 2 · withdrawn Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028496Phase 1 · completed Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01683110approved for marketing Expanded Access of Cabozantinib in Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068497NA · completed Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01739634Phase 1/Phase 2 · unknown The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01373736Phase 3 · unknown 123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine Tumors · condition mapped ALIAS · 128 trials mapped (52 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |